Matched-samples comparison of intramuscular versus vaginal progesterone for luteal phase support after in vitro fertilization and embryo transfer.

[1]  C. Racowsky,et al.  Comparison of Crinone 8% intravaginal gel and intramuscular progesterone supplementation for in vitro fertilization/embryo transfer in women under age 40: interim analysis of a prospective randomized trial. , 2008, Fertility and sterility.

[2]  J. Nulsen,et al.  Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function , 2007, Current opinion in obstetrics & gynecology.

[3]  R. Paulson,et al.  Endometrin® for Luteal Phase Support in a Randomized, Controlled, Open-Label, Prospective IVF Clinical Trial Using a Combination of Menopur® and Bravelle® , 2007 .

[4]  P. Ho,et al.  A randomized comparison of side effects and patient convenience between Cyclogest suppositories and Endometrin tablets used for luteal phase support in IVF treatment. , 2007, European journal of obstetrics, gynecology, and reproductive biology.

[5]  D. Grové,et al.  Luteal Phase Support in in vitro Fertilization: Meta-Analysis of Randomized Trials , 2005, Gynecologic and Obstetric Investigation.

[6]  S. Daya,et al.  WITHDRAWN: Luteal phase support in assisted reproduction cycles. , 2008, The Cochrane database of systematic reviews.

[7]  M. Aktan,et al.  Comparison of Pregnancy Outcomes of Progesterone or Progesterone + Estradiol for Luteal Phase Support in ICSI-ET Cycles , 2004, Gynecologic and Obstetric Investigation.

[8]  E. Ginsburg,et al.  A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. , 2001, Fertility and sterility.

[9]  W. Schoolcraft,et al.  Experience with progesterone gel for luteal support in a highly successful IVF programme. , 2000, Human reproduction.

[10]  A. Weissman,et al.  Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles. , 2000, Fertility and sterility.

[11]  N. Watson,et al.  Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women(3). , 2000, Fertility and sterility.

[12]  D. McIntire,et al.  Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles. , 1999, Fertility and sterility.

[13]  J. Grifo,et al.  Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study. , 1999, Fertility and sterility.

[14]  P. Kolm,et al.  Experience with a novel vaginal progesterone preparation in a donor oocyte program. , 1998, Fertility and sterility.

[15]  R. Frydman,et al.  Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone. , 1996, Human reproduction.

[16]  P. Kroboth,et al.  Oral Administration of Micronized Progesterone: A Review and More Experience , 1996, Pharmacotherapy.

[17]  R. Fanchin,et al.  Hormonal Control of Endometrial Receptivity , 1994, Annals of the New York Academy of Sciences.

[18]  M. Sauer,et al.  Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. , 1994, Fertility and sterility.

[19]  S. Daya.  Ovulation Induction for Corpus Luteum Deficiency , 1990 .

[20]  P. Devroey,et al.  The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. , 1988, Human reproduction.

[21]  R. Frydman,et al.  Hormonal and histological study of the luteal phase in women following aspiration of the preovulatory follicle. , 1982, Fertility and sterility.

[22]  J. Garcia,et al.  Corpus luteum function after follicle aspiration for oocyte retrieval. , 1981, Fertility and sterility.

[23]  M. Ferin,et al.  Mechanisms regulating the menstrual cycle in women. , 1970, Recent progress in hormone research.